Correction: LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway.

J Cancer Res Clin Oncol

Department of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnosis and Translation Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.

Published: March 2023

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-022-04568-zDOI Listing

Publication Analysis

Top Keywords

correction lncrna
4
lncrna uca1
4
uca1 promoted
4
promoted cisplatin
4
cisplatin resistance
4
resistance lung
4
lung adenocarcinoma
4
adenocarcinoma ho1
4
ho1 targets
4
targets nrf2/ho1
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!